These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18991739)

  • 1. Down-regulation of Notch1 expression is involved in HL-60 cell growth inhibition induced by 4-hydroxynonenal, a product of lipid peroxidation.
    Pizzimenti S; Barrera G; Calzavara E; Mirandola L; Toaldo C; Dianzani MU; Comi P; Chiaramonte R
    Med Chem; 2008 Nov; 4(6):551-7. PubMed ID: 18991739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation.
    Pizzimenti S; Ferracin M; Sabbioni S; Toaldo C; Pettazzoni P; Dianzani MU; Negrini M; Barrera G
    Free Radic Biol Med; 2009 Jan; 46(2):282-8. PubMed ID: 19022373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity.
    Pizzimenti S; Menegatti E; Berardi D; Toaldo C; Pettazzoni P; Minelli R; Giglioni B; Cerbone A; Dianzani MU; Ferretti C; Barrera G
    J Nutr Biochem; 2010 Sep; 21(9):818-26. PubMed ID: 19733043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines.
    Pizzimenti S; Briatore F; Laurora S; Toaldo C; Maggio M; De Grandi M; Meaglia L; Menegatti E; Giglioni B; Dianzani MU; Barrera G
    Free Radic Biol Med; 2006 May; 40(9):1578-91. PubMed ID: 16632118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-hydroxynonenal and cell cycle.
    Barrera G; Pizzimenti S; Laurora S; Briatore F; Toaldo C; Dianzani MU
    Biofactors; 2005; 24(1-4):151-7. PubMed ID: 16403975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors.
    Silva A; Jotta PY; Silveira AB; Ribeiro D; Brandalise SR; Yunes JA; Barata JT
    Haematologica; 2010 Apr; 95(4):674-8. PubMed ID: 20015880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation.
    Nagy N; Hajdu M; Márk Á; Király PA; Tóth M; Dankó T; Csóka M; Sebestyén A
    Tumour Biol; 2016 Oct; 37(10):13695-13704. PubMed ID: 27473087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism.
    Secchiero P; Melloni E; di Iasio MG; Tiribelli M; Rimondi E; Corallini F; Gattei V; Zauli G
    Blood; 2009 Apr; 113(18):4300-8. PubMed ID: 19190243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway.
    Barrera G; Pizzimenti S; Dianzani MU
    Free Radic Biol Med; 2004 Sep; 37(5):597-606. PubMed ID: 15288118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of Notch1 by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780.
    Wang M; Wu L; Wang L; Xin X
    Biochem Biophys Res Commun; 2010 Feb; 393(1):144-9. PubMed ID: 20117093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
    Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
    J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of differentiation in human HL-60 cells by 4-hydroxynonenal, a product of lipid peroxidation.
    Barrera G; Di Mauro C; Muraca R; Ferrero D; Cavalli G; Fazio VM; Paradisi L; Dianzani MU
    Exp Cell Res; 1991 Dec; 197(2):148-52. PubMed ID: 1959552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells.
    Duan L; Yao J; Wu X; Fan M
    Biol Cell; 2006 Aug; 98(8):479-90. PubMed ID: 16608439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of D1, D2, and A-cyclin expression in HL-60 cells by the lipid peroxydation product 4-hydroxynonenal.
    Pizzimenti S; Barrera G; Dianzani MU; Brüsselbach S
    Free Radic Biol Med; 1999 Jun; 26(11-12):1578-86. PubMed ID: 10401624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
    Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
    Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells.
    Cerbone A; Toaldo C; Laurora S; Briatore F; Pizzimenti S; Dianzani MU; Ferretti C; Barrera G
    Free Radic Biol Med; 2007 Jun; 42(11):1661-70. PubMed ID: 17462534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors.
    Palomero T; Barnes KC; Real PJ; Glade Bender JL; Sulis ML; Murty VV; Colovai AI; Balbin M; Ferrando AA
    Leukemia; 2006 Jul; 20(7):1279-87. PubMed ID: 16688224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related differential growth rate and response to 4-hydroxynonenal in mouse aortic smooth muscle cells.
    Lee TJ; Lee JT; Moon SK; Kim CH; Park JW; Kwon TK
    Int J Mol Med; 2006 Jan; 17(1):29-35. PubMed ID: 16328008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.